Drug & supplement interaction

Slippery Elm + ADO-Trastuzumab Emtansine

ADO-Trastuzumab Emtansine brand name: Kadcyla.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Slippery Elm and ADO-Trastuzumab Emtansine in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Slippery Elm and ADO-Trastuzumab Emtansine

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between ADO-Trastuzumab Emtansine and Slippery Elm in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Slippery Elm safety at a glance

Slippery Elm overall Use caution Generally well tolerated for short-term use, but high-quality safety data are limited.
Pregnancy Use caution Not enough reliable safety data; some sources caution against using it during pregnancy.
Breastfeeding Use caution There is too little information on safety while breastfeeding, so caution is advised.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining ADO-Trastuzumab Emtansine and Slippery Elm? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for ADO-Trastuzumab Emtansine

Interactions in our licensed database are recorded against drug classes, not just single drug names. ADO-Trastuzumab Emtansine is filed under a single classification — cytochrome p450 3a4 (cyp3a4) substrates. Slippery Elm has documented interactions with 1 drug class — the most serious being oral drugs (moderate) — and none of ADO-Trastuzumab Emtansine’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Slippery Elm Does Interact With Other Medications

Slippery Elm has 2,022 moderate known drug interactions in our database — ADO-Trastuzumab Emtansine isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Slippery Elm

Covers the 2,830 medications we’ve checked against Slippery Elm. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Slippery Elm and ADO-Trastuzumab Emtansine May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do.

  • A skin rash Additional detail

    Slippery Elm

    “Topically, slippery elm extracts can cause contact dermatitis. The pollen is an allergen (6). Contact dermatitis and urticaria have been reported after exposure to slippery elm or an oleoresin contained in the slippery elm bark.”

    Slippery Elm · Natural Medicines adverse-effect record, reported in dermatitis.

    2 sources cited
    1. 6. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
    2. 75131. Czarnecki D, Nixon R, Bekhor P, and et al. Delayed prolonged contact urticaria from the elm tree. Contact Dermatitis 1993;28:196-197. PubMed

    ADO-Trastuzumab Emtansine

    Listed in the ADVERSE REACTIONS section of the FDA label for ADO-Trastuzumab Emtansine. Read the label on DailyMed ›

Reported for Slippery Elm but not commonly for ADO-Trastuzumab Emtansine: hives.

Effects for ADO-Trastuzumab Emtansine come from the ADVERSE REACTIONS section of its FDA label; effects for Slippery Elm come from the Natural Medicines adverse-effect record, quoted above. Where a percentage is shown, it is the share of 8,277 voluntary FDA FAERS reports for ADO-Trastuzumab Emtansine that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Overlapping uses

What ADO-Trastuzumab Emtansine Is Prescribed For, and What Slippery Elm Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. ADO-Trastuzumab Emtansine is a prescription medicine with approved uses on its FDA label. Slippery Elm is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

ADO-Trastuzumab Emtansine is prescribed for: Kadcyla is used by itself (as a single agent) for HER2-positive breast cancer in two situations. Your tumor must test positive for HER2 using an FDA-authorized test. Metastatic breast cancer: for people who already received trastuzumab and a taxane, and who either had treatment for metastatic disease or whose cancer returned during or within six months of finishing adjuvant (after-surgery) therapy. Early breast cancer: as adjuvant treatment for people who still have residual invasive disease after neoadjuvant (pre-surgery) taxane and trastuzumab-based treatment.

Slippery Elm has been studied for:

  • Cancer studied, not established Slippery Elm has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Slippery Elm for cancer

    Oral slippery elm has only been evaluated in combination with other ingredients; its effect when used alone is unclear.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace ADO-Trastuzumab Emtansine on your own; if you are taking Slippery Elm for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

From our Q&A

Questions About Slippery Elm or ADO-Trastuzumab Emtansine

These are real questions from readers, answered by the pharmacists at HelloPharmacist — written by a person, not generated from a database. Each one covers Slippery Elm or ADO-Trastuzumab Emtansine, not necessarily both, but if one is close to what you were about to ask it will usually go further than a database entry can:

Not quite your question? Ask our pharmacists directly — it is free, there is no account required, and answers usually come back within 24 hours.

Everything else you take

See Every Supplement That Interacts With ADO-Trastuzumab Emtansine

This page covers Slippery Elm only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the ADO-Trastuzumab Emtansine page lists 121 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Grapefruit (major), St. John's Wort (major), Acacia Rigidula (moderate), Adrafinil (moderate) and African Wild Potato (moderate).

By severity: 2 major · 87 moderate · 32 minor.

From our pharmacist’s overview on the ADO-Trastuzumab Emtansine page

“If you're taking ado-trastuzumab emtansine (Kadcyla) for HER2-positive breast cancer, treat this list as one to check carefully, not casually. Every one of the 121 flagged ingredients affects the same enzyme, CYP3A4, which your body uses to clear part of this medicine.”

Reviewed by 2 · Jul 18, 2026

Open the ADO-Trastuzumab Emtansine interaction page

One more smart check

Taking Slippery Elm as Part of a Dietary Supplement Product? Check It for Interactions

We hold 1,490 real supplement products containing Slippery Elm, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Slippery Elm. Even though Slippery Elm itself has no known interaction with ADO-Trastuzumab Emtansine, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Slippery Elm and ADO-Trastuzumab Emtansine Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Slippery Elm
Top 10%

#111 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication ADO-Trastuzumab Emtansine
Top 5%

#73 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Slippery Elm reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified October 4, 2026. The Slippery Elm and ADO-Trastuzumab Emtansine records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Slippery Elm

What is Slippery Elm?

Slippery Elm
  • Sore throat and cough
  • Heartburn and acid reflux
  • Digestive upset and IBS
  • Skin irritation (topical)
  • Constipation or diarrhea

Slippery elm is a traditional herbal remedy made from the inner bark of a North American elm tree, used mainly to soothe sore throats and irritated digestive tracts. Its mucilage can coat and calm mucous membranes, but solid human evidence for most uses is limited. It is generally considered low-risk for short-term use, but you should still check with your pharmacist or doctor first.

Ulmus rubra · Ulmaceae · Inner bark · Capsules, tablets, lozenges, powder, tea, throat lozenges, topical pastes

An interaction check asks whether these two react with each other — it does not ask whether Slippery Elm is a good idea for someone in your situation. Here is what our Slippery Elm record says about it on its own.

Slippery Elm: dosing

There is no official standardized dose for slippery elm. The right amount can vary depending on the form (lozenge, capsule, powder, or tea) and the product.The safest approach is to follow the directions on the product label. When using the powder or capsules, take them with a full glass of water.

From our Slippery Elm monograph — the full record covers uses, side effects and every documented interaction.

Read the full Slippery Elm monograph & all interactions
Medication

About Ado-trastuzumab Emtansine Injection

What Is Ado-trastuzumab Emtansine Injection Used For?

Brand name: Kadcyla

Kadcyla is used by itself (as a single agent) for HER2-positive breast cancer in two situations. Your tumor must test positive for HER2 using an FDA-authorized test.

  • Metastatic breast cancer: for people who already received trastuzumab and a taxane, and who either had treatment for metastatic disease or whose cancer returned during or within six months of finishing adjuvant (after-surgery) therapy.
  • Early breast cancer: as adjuvant treatment for people who still have residual invasive disease after neoadjuvant (pre-surgery) taxane and trastuzumab-based treatment.

Most-Reported Side Effects for ADO-Trastuzumab Emtansine

From FAERS, the FDA’s public side-effect reporting system (8,277 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Disease progression 781 reports
Fatigue 751 reports
Nausea 732 reports
Diarrhea 594 reports
Thrombocytopenia 468 reports
See full Ado-trastuzumab Emtansine Injection drug information
Keep checking

Other Drugs & Slippery Elm

Browse every other medication we’ve checked against Slippery Elm — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
2,022Moderate
0Minor
807No known interaction
Moderate

2,022 interactions

Showing 60 of 2,022 moderate interactions — see all 2,022 on the Slippery Elm page.

No interaction 807 drugs checked — show the list

We also checked Slippery Elm against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 807 medications checked with no known interaction — see the full Slippery Elm list.

Evidence & sources

Slippery Elm References

The 3 references that drive our Slippery Elm monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
  2. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
  3. Czarnecki D, Nixon R, Bekhor P, and et al. Delayed prolonged contact urticaria from the elm tree. Contact Dermatitis 1993;28:196-197. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Slippery Elm and ADO-Trastuzumab Emtansine Together: Common Questions

Is it safe to take Slippery Elm with ADO-Trastuzumab Emtansine?
We do not list a known interaction between Slippery Elm and ADO-Trastuzumab Emtansine. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Slippery Elm and ADO-Trastuzumab Emtansine have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Slippery Elm and ADO-Trastuzumab Emtansine used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Slippery Elm in each. That is a conversation for your prescriber, especially if ADO-Trastuzumab Emtansine is being adjusted to a target.
How was the Slippery Elm and ADO-Trastuzumab Emtansine combination checked?
Interactions in our licensed database are recorded against drug classes. ADO-Trastuzumab Emtansine is filed under 1 classification, and Slippery Elm has documented interactions with 1 drug class — none of ADO-Trastuzumab Emtansine's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Slippery Elm interact with any other medications?
Yes. Slippery Elm has 2,022 documented drug interactions in our database — ADO-Trastuzumab Emtansine is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does ADO-Trastuzumab Emtansine interact with any supplements?
Yes. ADO-Trastuzumab Emtansine has documented interactions with 121 supplements in our database — Slippery Elm is not one of them. The ADO-Trastuzumab Emtansine interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About ADO-Trastuzumab Emtansine and Slippery Elm?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.